Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis

Blaser J, Triebel S, Maasjosthusmann U, Romisch J, KrahlMateblowski U, Freudenberg W, Fricke R, Tschesche H (1996)
CLINICA CHIMICA ACTA 244(1): 17-33.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ;
Abstract / Bemerkung
The concentrations of matrix metalloproteinase-l (MMP-1), matrix metalloproteinase-8 (MMP-8), matrix metalloproteinase-9 (MMP-8), lactoferrin and urokinase plasminogen activator (uPA), tissue-type plasminogen activator (tPA) and the inhibitors, tissue inhibitor of metalloproteinase-l (TIMP-1), plasminogen activator inhibitor-1 (PAI-1), plasminogen activator inhibitor (PAI-2), and alpha(2)-macroglobulin in the synovial fluids of patients with rheumatoid arthritis was determined before and during chemical synoviorthesis with a sodium salt of the fatty acids from cod-liver oil (Varicocid). synovial fluids were obtained before treatment from 37 patients with rheumatoid arthritis and, in most cases, at 8 and 24 h after injection of the agent. Well-established ELISAs were used to determine the amounts of all proteins. All patients with rheumatoid arthritis revealed very high levels of metalloproteinases (about 1-15 mu g/ml) in their synovial fluids. During the inflammation inducing treatment the granulocyte enzymes increased. In contrast to this, the level of MMP-1 decreased. All granulocyte-derived enzymes were strongly correlated with each other, whereas their dependence on the granulocyte count was only weak. uPA and PAI-2 showed good correlations with the granulocytes-derived enzymes, but were also only weakly correlating with the cell counts. tPA was not detected by the ELISA used. The proteases, MMP-8, MMP9 and uPA were increased 8 h after the treatment, whereas the specific inhibitors TIMP-1, PAI-1 and PAI-2 showed significant changes only 24 h after the injection. Matrix metalloproteinases are important factors in the pathogenesis of rheumatoid arthritis. The inflammatory activity in the joint could be better correlated to the granulocyte enzymes than to the granulocyte counts. The levels of uPA and PA1-2 are also parallel to the granulocyte enzyme levels and might underly the same regulatory mechanism.
Erscheinungsjahr
Zeitschriftentitel
CLINICA CHIMICA ACTA
Band
244
Ausgabe
1
Seite(n)
17-33
ISSN
PUB-ID

Zitieren

Blaser J, Triebel S, Maasjosthusmann U, et al. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA. 1996;244(1):17-33.
Blaser, J., Triebel, S., Maasjosthusmann, U., Romisch, J., KrahlMateblowski, U., Freudenberg, W., Fricke, R., et al. (1996). Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA, 244(1), 17-33. doi:10.1016/0009-8981(95)06172-X
Blaser, J., Triebel, S., Maasjosthusmann, U., Romisch, J., KrahlMateblowski, U., Freudenberg, W., Fricke, R., and Tschesche, H. (1996). Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA 244, 17-33.
Blaser, J., et al., 1996. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA, 244(1), p 17-33.
J. Blaser, et al., “Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis”, CLINICA CHIMICA ACTA, vol. 244, 1996, pp. 17-33.
Blaser, J., Triebel, S., Maasjosthusmann, U., Romisch, J., KrahlMateblowski, U., Freudenberg, W., Fricke, R., Tschesche, H.: Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis. CLINICA CHIMICA ACTA. 244, 17-33 (1996).
Blaser, J, Triebel, S, Maasjosthusmann, U, Romisch, J, KrahlMateblowski, U, Freudenberg, W, Fricke, R, and Tschesche, Harald. “Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis”. CLINICA CHIMICA ACTA 244.1 (1996): 17-33.

19 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Apolipoprotein A-I proteolysis in aortic valve stenosis: role of cathepsin S.
Gebhard C, Maafi F, Stähli BE, Dang J, Nachar W, de Oliveira Moraes AB, Kernaleguen AE, Lavoie V, Mecteau M, Mihalache-Avram T, Shi Y, Chabot-Blanchet M, Busseuil D, Rhainds D, Rhéaume E, Tardif JC., Basic Res Cardiol 113(4), 2018
PMID: 29915952
Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy.
Kurgan Ş, Önder C, Balcı N, Fentoğlu Ö, Eser F, Balseven M, Serdar MA, Tatakis DN, Günhan M., J Periodontal Res 52(3), 2017
PMID: 27781272
The impact of chemical synovectomy with sodium morrhuate on human chondrocytes and cartilage in vitro.
Winkler S, Grässel S, Baier C, Anders S, Lechler P, Grifka J, Schaumburger J., Rheumatol Int 33(5), 2013
PMID: 22983137
Structure of matrix metalloproteinase-3 with a platinum-based inhibitor.
Belviso BD, Caliandro R, Siliqi D, Calderone V, Arnesano F, Natile G., Chem Commun (Camb) 49(48), 2013
PMID: 23660647
Orally active, antimetastatic, nontoxic diphenyl ether-derived carbamoylphosphonate matrix metalloproteinase inhibitors.
Frant J, Veerendhar A, Chernilovsky T, Nedvetzki S, Vaksman O, Hoffman A, Breuer E, Reich R., ChemMedChem 6(8), 2011
PMID: 21656908
Signal transduction and metabolism in chondrocytes is modulated by lactoferrin.
Brandl N, Zemann A, Kaupe I, Marlovits S, Huettinger P, Goldenberg H, Huettinger M., Osteoarthritis Cartilage 18(1), 2010
PMID: 19747587
Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M, Campestre C, Preziuso S, Consalvi V, Crucianelli M, Mazza F, Politi V, Ragno R, Tortorella P, Gallina C., Eur J Med Chem 40(3), 2005
PMID: 15725496
Tumor necrosis factor-alpha increases chemokine gene expression and production in synovial fibroblasts from human temporomandibular joint.
Ogura N, Tobe M, Sakamaki H, Nagura H, Abiko Y, Kondoh T., J Oral Pathol Med 34(6), 2005
PMID: 15946184
Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.
Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J., Rheumatology (Oxford) 41(1), 2002
PMID: 11792884
Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.
Hudlicky T, Oppong K, Duan C, Stanton C, Laufersweiler MJ, Natchus MG., Bioorg Med Chem Lett 11(5), 2001
PMID: 11266157
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R, Lee JM, Hoxworth JM, Smith D, Duray P, Schumacher RH, Yarboro CH, Klippel J, Kleiner D, El-Gabalawy HS., Arthritis Res 2(2), 2000
PMID: 11062605
Autocrine induction of gliostatin/platelet-derived endothelial cell growth factor (GLS/PD-ECGF) and GLS-induced expression of matrix metalloproteinases in rheumatoid arthritis synoviocytes.
Muro H, Waguri-Nagaya Y, Mukofujiwara Y, Iwahashi T, Otsuka T, Matsui N, Moriyama A, Asai K, Kato T., Rheumatology (Oxford) 38(12), 1999
PMID: 10587545

37 References

Daten bereitgestellt von Europe PubMed Central.

Collagenase at sites of cartilage erosion in the rheumatoid joint.
Woolley DE, Crossley MJ, Evanson JM., Arthritis Rheum. 20(6), 1977
PMID: 71152
Matrix metalloproteinases: a review.
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA., Crit. Rev. Oral Biol. Med. 4(2), 1993
PMID: 8435466
Activation of latent collagenase by serum proteinases that interact with immobilized immunoglobulin G.
Armour PC, Levi S, Golds EE, Poole AR, Mort JS, Roughley PJ., Rheumatol. Int. 4(4), 1984
PMID: 6091234
Biologial effects of the human complement fragments C5a and C5ades Arg on neutrophil function.
Webster RO, Hong SR, Johnston RB Jr, Henson PM., Immunopharmacology 2(3), 1980
PMID: 6254906
Synovial tissue macrophage as a source of the chemotactic cytokine IL-8.
Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Strieter RM., J. Immunol. 147(7), 1991
PMID: 1918955
Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.
Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, Matsushima K, Feldmann M., Eur. J. Immunol. 20(9), 1990
PMID: 2209707
The role of the neutrophil in rheumatoid arthritis
Kitsis, CIin Orthop 265(), 1991
Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H, Knauper V, Kramer S, Michaelis J, Oberhoff R, Reinke H., Matrix Suppl 1(), 1992
PMID: 1480034
Oxidative autoactivation of latent collagenase by human neutrophils.
Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST., Science 227(4688), 1985
PMID: 2982211
Degradation of human articular cartilage by neutrophils in synovial fluid.
Chatham WW, Swaim R, Frohsin H Jr, Heck LW, Miller EJ, Blackburn WD Jr., Arthritis Rheum. 36(1), 1993
PMID: 8424836
Lysis of fibrillar collagen by neutrophils in synovial fluid. A role for surface-bound immunoglobulins.
Chatham WW, Heck LW, Blackburn WD Jr., Arthritis Rheum. 33(9), 1990
PMID: 2169747
Proteolytic inactivation of alpha 1-antitrypsin and alpha 1-antichymotrypsin by neutrophils in arthritic joints.
Abbink JJ, Kamp AM, Nuijens JH, Swaak TJ, Hack CE., Arthritis Rheum. 36(2), 1993
PMID: 8431205
Human neutrophil collagenase cleaves alpha 1-antitrypsin.
Michaelis J, Vissers MC, Winterbourn CC., Biochem. J. 270(3), 1990
PMID: 2173552
Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase.
Knauper V, Reinke H, Tschesche H., FEBS Lett. 263(2), 1990
PMID: 2159425
Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases.
Knauper V, Triebel S, Reinke H, Tschesche H., FEBS Lett. 290(1-2), 1991
PMID: 1655539
Chemical synovectomy by sodium salt of fatty acid
Niculescu, Zschr Rheumaforsch 29(), 1970
Cytological and biochemical changes in the synovial fluid after treatment with Varicocid
Kätner, Zschr Inn Med 28(), 1973
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS., Arthritis Rheum. 31(3), 1988
PMID: 3358796
Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.
Larsen A, Dale K, Eek M., Acta Radiol Diagn (Stockh) 18(4), 1977
PMID: 920239
Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase.
Bergmann U, Michaelis J, Oberhoff R, Knauper V, Beckmann R, Tschesche H., J. Clin. Chem. Clin. Biochem. 27(6), 1989
PMID: 2547014
Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes.
Gunther M, Haubeck HD, van de Leur E, Blaser J, Bender S, Gutgemann I, Fischer DC, Tschesche H, Greiling H, Heinrich PC., Arthritis Rheum. 37(3), 1994
PMID: 8129795
Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium.
Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T., Virchows Arch., B, Cell Pathol. 59(5), 1990
PMID: 1980561
In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium.
Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH., Arthritis Rheum. 34(9), 1991
PMID: 1657007
Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry.
McCachren SS, Haynes BF, Niedel JE., J. Clin. Immunol. 10(1), 1990
PMID: 2155914
Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW., Arthritis Rheum. 35(1), 1992
PMID: 1370619
Collagenase reserves in polymorphonuclear neutrophil leukocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis.
Konttinen YT, Lindy O, Kemppinen P, Saari H, Suomalainen K, Vauhkonen M, Lindy S, Sorsa T., Matrix 11(4), 1991
PMID: 1656176
Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator inhibitor 1 in human synovial fibroblasts.
Hamilton JA, Cheung D, Filonzi EL, Piccoli DS, Wojta J, Gallichio M, McGrath K, Last K., Arthritis Rheum. 35(12), 1992
PMID: 1472130
The receptor for urokinase-type plasminogen activator and urokinase is translocated from two distinct intracellular compartments to the plasma membrane on stimulation of human neutrophils.
Plesner T, Ploug M, Ellis V, Ronne E, Hoyer-Hansen G, Wittrup M, Pedersen TL, Tscherning T, Dano K, Hansen NE., Blood 83(3), 1994
PMID: 8298141
Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils.
Gudewicz PW, Gilboa N., Biochem. Biophys. Res. Commun. 147(3), 1987
PMID: 3117059
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines
Yoshimura, 1987

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 8919199
PubMed | Europe PMC

Suchen in

Google Scholar